Package 21130-813-10

Brand: signature care nasal decongestant

Generic: oxymetazoline hydrochloride
NDC Package

Package Facts

Identity

Package NDC 21130-813-10
Digits Only 2113081310
Product NDC 21130-813
Product ID 21130-813_0492955a-6e24-4b31-bf42-3b877a750d3c
Description

1 BOTTLE, SPRAY in 1 CARTON (21130-813-10) / 30 mL in 1 BOTTLE, SPRAY

Marketing

Marketing Status
Marketed Since 2019-05-31
Brand signature care nasal decongestant
Generic oxymetazoline hydrochloride
Sample Package No

Linked Drug Pages (1)

signature care nasal decongestant ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["NASAL"], "spl_id": "0492955a-6e24-4b31-bf42-3b877a750d3c", "openfda": {"unii": ["K89MJ0S5VY"], "rxcui": ["1000990"], "spl_set_id": ["f9ac80d1-3753-412b-a407-18a6b50e5d1c"], "manufacturer_name": ["Safeway"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, SPRAY in 1 CARTON (21130-813-10)  / 30 mL in 1 BOTTLE, SPRAY", "package_ndc": "21130-813-10", "marketing_start_date": "20190531"}], "brand_name": "signature care nasal decongestant", "product_id": "21130-813_0492955a-6e24-4b31-bf42-3b877a750d3c", "dosage_form": "SPRAY, METERED", "pharm_class": ["Imidazolines [CS]", "Increased Sympathetic Activity [PE]", "Vasoconstriction [PE]", "Vasoconstrictor [EPC]"], "product_ndc": "21130-813", "generic_name": "oxymetazoline hydrochloride", "labeler_name": "Safeway", "product_type": "HUMAN OTC DRUG", "brand_name_base": "signature care nasal decongestant", "active_ingredients": [{"name": "OXYMETAZOLINE HYDROCHLORIDE", "strength": ".05 g/100mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20190531", "listing_expiration_date": "20261231"}